{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:48:17Z","timestamp":1791316097534,"version":"4.3.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T00:00:00Z","timestamp":1481587200000},"content-version":"vor","delay-in-days":73,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1038\/mt.2016.152","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T07:21:48Z","timestamp":1469517708000},"page":"1797-1805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Somatic Therapy of a Mouse SMA Model with a U7 snRNA Gene Correcting SMN2 Splicing"],"prefix":"10.1016","volume":"24","author":[{"given":"Philipp","family":"Odermatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Tr\u00fcb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Furrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Fricker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Marti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sch\u00fcmperli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2016.152_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/nbdi.1996.0010","article-title":"The neurobiology of childhood spinal muscular atrophy","volume":"3","author":"Crawford","year":"1996","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mt.2016.152_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"10.1038\/mt.2016.152_bib3","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/S0140-6736(08)60921-6","article-title":"Spinal muscular atrophy","volume":"371","author":"Lunn","year":"2008","journal-title":"Lancet"},{"key":"10.1038\/mt.2016.152_bib4","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1128\/MCB.01262-08","article-title":"Regulation of SMN protein stability","volume":"29","author":"Burnett","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1038\/mt.2016.152_bib5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ng854","article-title":"Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1","volume":"30","author":"Cartegni","year":"2002","journal-title":"Nat Genet"},{"key":"10.1038\/mt.2016.152_bib6","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/ng1207","article-title":"A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy","volume":"34","author":"Kashima","year":"2003","journal-title":"Nat Genet"},{"key":"10.1038\/mt.2016.152_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1086\/498853","article-title":"Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2","volume":"78","author":"Cartegni","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1038\/mt.2016.152_bib8","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1093\/hmg\/ddm276","article-title":"hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing","volume":"16","author":"Kashima","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2016.152_bib9","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/sj.mt.6300200","article-title":"Spinal muscular atrophy: SMN2 pre-mRNA splicing corrected by a U7 snRNA derivative carrying a splicing enhancer sequence","volume":"15","author":"Marquis","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.152_bib10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/hmg\/9.3.333","article-title":"The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in SMN(\u2212\/\u2212) mice and results in a mouse with spinal muscular atrophy","volume":"9","author":"Monani","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2016.152_bib11","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/hmg\/ddn382","article-title":"Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation","volume":"18","author":"Meyer","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2016.152_bib12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4161\/rna.7.4.12206","article-title":"Repair of pre-mRNA splicing: prospects for a therapy for spinal muscular atrophy","volume":"7","author":"Nlend Nlend","year":"2010","journal-title":"RNA Biol"},{"key":"10.1038\/mt.2016.152_bib13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1089\/hum.2012.225","article-title":"Antisense oligonucleotides for the treatment of spinal muscular atrophy","volume":"24","author":"Porensky","year":"2013","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2016.152_bib14","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/hmg\/ddi078","article-title":"SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN","volume":"14","author":"Le","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2016.152_bib15","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajhg.2008.01.014","article-title":"Antisense masking of an hnRNP A1\/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice","volume":"82","author":"Hua","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1038\/mt.2016.152_bib16","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1101\/gad.256644.114","article-title":"Motor neuron cell-nonautonomous rescue of spinal muscular atrophy phenotypes in mild and severe transgenic mouse models","volume":"29","author":"Hua","year":"2015","journal-title":"Genes Dev"},{"key":"10.1038\/mt.2016.152_bib17","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI41615","article-title":"CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy","volume":"120","author":"Passini","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2016.152_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","article-title":"Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN","volume":"28","author":"Foust","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2016.152_bib19","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/hmg\/ddq514","article-title":"Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice","volume":"20","author":"Dominguez","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2016.152_bib20","doi-asserted-by":"crossref","first-page":"35ra42","DOI":"10.1126\/scitranslmed.3000830","article-title":"Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy","volume":"2","author":"Valori","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1038\/mt.2016.152_bib21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.bbrc.2011.11.121","article-title":"Direct central nervous system delivery provides enhanced protection following vector mediated gene replacement in a severe model of spinal muscular atrophy","volume":"417","author":"Glascock","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/mt.2016.152_bib22","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/mt.2009.71","article-title":"Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons","volume":"17","author":"Duque","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.152_bib23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1517\/14728214.2015.1041375","article-title":"Moving towards treatments for spinal muscular atrophy: hopes and limits","volume":"20","author":"Wirth","year":"2015","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1038\/mt.2016.152_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0167-4781(91)90167-K","article-title":"Isolation of an active gene and of two pseudogenes for mouse U7 small nuclear RNA","volume":"1088","author":"Gruber","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"10.1038\/mt.2016.152_bib25","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/sj.gt.3301550","article-title":"An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA","volume":"8","author":"Zhang","year":"2001","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2016.152_bib26","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/mt.2009.255","article-title":"Effect of genome size on AAV vector packaging","volume":"18","author":"Wu","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.152_bib27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/mt.2014.210","article-title":"Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose-response study in mice and nonhuman primates","volume":"23","author":"Meyer","year":"2015","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.152_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2016.152_bib29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.nbd.2007.04.009","article-title":"Abnormal motor phenotype in the SMNDelta7 mouse model of spinal muscular atrophy","volume":"27","author":"Butchbach","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mt.2016.152_bib30","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1080\/15476286.2014.996494","article-title":"Splicing changes in SMA mouse motoneurons and SMN-depleted neuroblastoma cells: evidence for involvement of splicing regulatory proteins","volume":"11","author":"Huo","year":"2014","journal-title":"RNA Biol"},{"key":"10.1038\/mt.2016.152_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jnr.22189","article-title":"Neurodevelopmental consequences of Smn depletion in a mouse model of spinal muscular atrophy","volume":"88","author":"Liu","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.1038\/mt.2016.152_bib32","doi-asserted-by":"crossref","first-page":"e1000773","DOI":"10.1371\/journal.pgen.1000773","article-title":"Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy","volume":"5","author":"B\u00e4umer","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1038\/mt.2016.152_bib33","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cell.2008.03.031","article-title":"SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing","volume":"133","author":"Zhang","year":"2008","journal-title":"Cell"},{"key":"10.1038\/mt.2016.152_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mcn.2015.11.007","article-title":"Central and peripheral defects in motor units of the diaphragm of spinal muscular atrophy mice","volume":"70","author":"Neve","year":"2016","journal-title":"Mol Cell Neurosci"},{"key":"10.1038\/mt.2016.152_bib35","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/mt.2011.157","article-title":"Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders","volume":"19","author":"Bevan","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.152_bib36","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ana.24332","article-title":"A large animal model of spinal muscular atrophy and correction of phenotype","volume":"77","author":"Duque","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1038\/mt.2016.152_bib37","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/mt.2008.171","article-title":"Self-complementary AAV vectors; advances and applications","volume":"16","author":"McCarty","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.152_bib38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature10485","article-title":"Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model","volume":"478","author":"Hua","year":"2011","journal-title":"Nature"},{"key":"10.1038\/mt.2016.152_bib39","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1146\/annurev.genet.37.110801.143717","article-title":"Integration of adeno-associated virus (AAV) and recombinant AAV vectors","volume":"38","author":"McCarty","year":"2004","journal-title":"Annu Rev Genet"},{"key":"10.1038\/mt.2016.152_bib40","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/mt.2012.47","article-title":"Integration frequency and intermolecular recombination of rAAV vectors in non-human primate skeletal muscle and liver","volume":"20","author":"Nowrouzi","year":"2012","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.152_bib41","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nm.3230","article-title":"A largely random AAV integration profile after LPLD gene therapy","volume":"19","author":"Kaeppel","year":"2013","journal-title":"Nat Med"},{"key":"10.1038\/mt.2016.152_bib42","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1126\/science.1142658","article-title":"AAV vector integration sites in mouse hepatocellular carcinoma","volume":"317","author":"Donsante","year":"2007","journal-title":"Science"},{"key":"10.1038\/mt.2016.152_bib43","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ymthe.2005.03.020","article-title":"No evidence for tumorigenesis of AAV vectors in a large-scale study in mice","volume":"12","author":"Bell","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.152_bib44","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1182\/blood-2010-08-302729","article-title":"Assessing the potential for AAV vector genotoxicity in a murine model","volume":"117","author":"Li","year":"2011","journal-title":"Blood"},{"key":"10.1038\/mt.2016.152_bib45","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/mt.2016.52","article-title":"Recombinant AAV Integration Is Not Associated With Hepatic Genotoxicity in Nonhuman Primates and Patients","volume":"24","author":"Gil-Farina","year":"2016","journal-title":"Mol Ther"},{"issue":"Pt 4","key":"10.1038\/mt.2016.152_bib46","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1042\/BST0360590","article-title":"Expression of human snRNA genes from beginning to end","volume":"36","author":"Egloff","year":"2008","journal-title":"Biochem Soc Trans"},{"key":"10.1038\/mt.2016.152_bib47","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.nmd.2010.06.010","article-title":"Ultrastructural changes in diaphragm neuromuscular junctions in a severe mouse model for Spinal Muscular Atrophy and their prevention by bifunctional U7 snRNA correcting SMN2 splicing","volume":"20","author":"Voigt","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"10.1038\/mt.2016.152_bib48","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/nan.12064","article-title":"The craniosacral progression of muscle development influences the emergence of neuromuscular junction alterations in a severe murine model for spinal muscular atrophy","volume":"40","author":"Voigt","year":"2014","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1038\/mt.2016.152_bib49","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/mt.2012.261","article-title":"Intramuscular scAAV9-SMN injection mediates widespread gene delivery to the spinal cord and decreases disease severity in SMA mice","volume":"21","author":"Benkhelifa-Ziyyat","year":"2013","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.152_bib50","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/hmg\/ddm379","article-title":"Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect","volume":"17","author":"Gavrilina","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2016.152_bib51","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1093\/hmg\/ddv283","article-title":"SMN expression is required in motor neurons to rescue electrophysiological deficits in the SMN\u03947 mouse model of SMA","volume":"24","author":"McGovern","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2016.152_bib52","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1172\/JCI66778","article-title":"Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy","volume":"123","author":"Haurigot","year":"2013","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1038\/mt.2016.152_bib53","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.152_bib54","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/jmg.2008.057950","article-title":"Congenital heart disease is a feature of severe infantile spinal muscular atrophy","volume":"45","author":"Rudnik-Sch\u00f6neborn","year":"2008","journal-title":"J Med Genet"},{"key":"10.1038\/mt.2016.152_bib55","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1093\/hmg\/ddq300","article-title":"Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery","volume":"19","author":"Bevan","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2016.152_bib56","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1093\/hmg\/ddq330","article-title":"Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice","volume":"19","author":"Heier","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2016.152_bib57","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1093\/hmg\/ddq329","article-title":"Cardiac defects contribute to the pathology of spinal muscular atrophy models","volume":"19","author":"Shababi","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2016.152_bib58","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1126\/science.1250127","article-title":"SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy","volume":"345","author":"Naryshkin","year":"2014","journal-title":"Science"},{"key":"10.1038\/mt.2016.152_bib59","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddw062","article-title":"Pharmacokinetics, pharmacodynamics and efficacy of a small molecule SMN2 splicing modifier in mouse models of spinal muscular atrophy","author":"Zhao","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2016.152_bib60","doi-asserted-by":"crossref","first-page":"11168","DOI":"10.1038\/ncomms11168","article-title":"Therapeutic activity of modified U1 core spliceosomal particles","volume":"7","author":"Rogalska","year":"2016","journal-title":"Nat Commun"},{"key":"10.1038\/mt.2016.152_bib61","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/mt.2008.73","article-title":"Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice","volume":"16","author":"Towne","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.152_bib62","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1093\/hmg\/dds082","article-title":"Rescue of severely affected dystrophin\/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping","volume":"21","author":"Goyenvalle","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2016.152_bib63","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1525-0016(03)00095-9","article-title":"Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6","volume":"7","author":"Grimm","year":"2003","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.152_bib64","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/gt.2008.138","article-title":"Doxycycline-controlled splicing modulation by regulated antisense U7 snRNA expression cassettes","volume":"16","author":"Marquis","year":"2009","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2016.152_bib65","first-page":"9711","article-title":"FUS\/TLS contributes to replication-dependent histone gene expression by interaction with U7 snRNPs and histone-specific transcription factors","volume":"43","author":"Raczynska","year":"2015","journal-title":"Nucleic Acids Res"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616454080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616454080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:52:14Z","timestamp":1761501134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616454080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":65,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1525001616454080"],"URL":"https:\/\/doi.org\/10.1038\/mt.2016.152","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Somatic Therapy of a Mouse SMA Model with a U7 snRNA Gene Correcting SMN2 Splicing","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mt.2016.152","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society of Gene & Cell Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}